Trends in Utilization of Transnasal Esophagoscopy

경비강 식도경의 임상적 활용

  • Park, Il-Seok (Department of Otorhinolaryngology-Head and Neck Surgery, Dongtan Sacred Heart Hospital, Hallym University College of Medicine)
  • 박일석 (한림대학교 의과대학 동탄성심병원 이비인후-두경외과학교실)
  • Received : 2017.11.15
  • Accepted : 2018.11.17
  • Published : 2018.12.30

Abstract

The development of office-based, unsedated transnasal esophagoscopy (TNE) has proven to be a major technological advance and with time and experience the application of this technology is becoming more widespread. TNE has allowed otolaryngologists to perform a variety of diagnostic and therapeutic procedures in the office setting. Studies consistently demonstrate that the image quality and diagnostic capability of TNE is equivalent to conventional esophagoscopy. The modern TNE endoscopes offer high quality optics, air-insufflation, and irrigation capability through a 2-mm working channel, and the ability to perform biopsies and select procedures. In general, the role of TNE in the head and neck patient is three-fold : to screen for synchronous and metachronous esophageal squamous cell carcinoma (ESCC) ; to differentiate post-treatment changes/symptoms from malignancy ; and to perform certain office-based procedures. TNE offers many specific advantages to the head and neck patient that are not afforded by conventional esophagoscopy. Because of surgical and postirradiation changes, many HNSCC patients have trismus or neck stiffness preventing completion of conventional transoral esophagoscopy. Perhaps most importantly, TNE provides enhanced patient safety, increased tolerability, better practice efficiency, and cost savings. For these reasons, TNE has become a particularly useful tool in the otolaryngologist's armamentarium.

Keywords

References

  1. Amin MR, Postma GN, Setzen M, Koufman JA. Transnasal esophagoscopy:a position statement from the American Bronchoesophagological Association (ABEA). Otolaryngol Head Neck Surg 2008; 138:411-4. https://doi.org/10.1016/j.otohns.2007.12.032
  2. Bush CM, Postma GN. Transnasal esophagoscopy. Otolaryngol Clin North Am 2013;46:41-52. https://doi.org/10.1016/j.otc.2012.08.016
  3. Dolan RW, Anderson TD. Practical applications of in-office fiberoptic transnasal esophagoscopy in the initial evaluation of patients with squamous cell cancer of the head and neck. Ear Nose Throat J 2013;92:450-5.
  4. Postma GN, Cohen JT, Belafsky PC, Halum SL, Gupta SK, Bach KK, et al. Transnasal esophagoscopy: revisited (over 700 consecutive cases). Laryngoscope 2005;115:321-3. https://doi.org/10.1097/01.mlg.0000154741.25443.fe
  5. Postma GN, Bach KK, Belafsky PC, Koufman JA. The role of transnasal esophagoscopy in head and neck oncology. Laryngoscope 2002;112:2242-3. https://doi.org/10.1097/00005537-200212000-00020
  6. Aviv JE. Transnasal esophagoscopy: state of the art. Otolaryngol Head Neck Surg 2006;135:616-9. https://doi.org/10.1016/j.otohns.2006.03.031
  7. Sabirin J, Abd Rahman M, Rajan P. Changing trends in oesophageal endoscopy: a systematic review of transnasal oesophagoscopy. ISRN Otolaryngol 2013;2013:586973.
  8. Angadi PV, Savitha JK, Rao SS, Sivaranjini Y. Oral field cancerization:current evidence and future perspectives. Oral Maxillofac Surg 2012;16:171-80. https://doi.org/10.1007/s10006-012-0317-x
  9. Hung SH, Tsai MC, Liu TC, Lin HC, Chung SD. Routine endoscopy for esophageal cancer is suggestive for patients with oral, oropharyngeal and hypopharyngeal cancer. PLoS One 2013;8:e72097. https://doi.org/10.1371/journal.pone.0072097
  10. Wang CH, Lee YC, Wang CP, Chen CC, Ko JY, Han ML, et al. Use of transnasal endoscopy for screening of esophageal squamous cell carcinoma in high-risk patients: yield rate, completion rate, and safety. Dig Endosc 2014;26:24-31. https://doi.org/10.1111/den.12053
  11. Lee WT, Akst LM, Adelstein DJ, Saxton JP, Wood BG, Strome M, et al. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation. Head Neck 2006;28:808-12. https://doi.org/10.1002/hed.20427
  12. Lee YC, Wang CP, Chen CC, Chiu HM, Ko JY, Lou PJ, et al. Transnasal endoscopy with narrow-band imaging and Lugol staining to screen patients with head and neck cancer whose condition limits oral intubation with standard endoscope (with video). Gastrointest Endosc 2009;69(3 Pt 1):408-17. https://doi.org/10.1016/j.gie.2008.05.033
  13. Su YY, Chen WC, Chuang HC, Guo CS, Lin YT, Luo SD, et al. Effect of routine esophageal screening in patients with head and neck cancer. JAMA Otolaryngol 2013;139:350-4.
  14. Lee KD, Lu CH, Chen PT, Chan CH, Lin JT, Huang CE, et al. The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period. BMC Cancer 2009;9:373. https://doi.org/10.1186/1471-2407-9-373
  15. Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol 2011;29:739-46. https://doi.org/10.1200/JCO.2010.31.8311
  16. Wang CP, Tseng PH, Chen TC, Lou PJ, Yang TL, Hu YL, et al. Transnasal esophagogastroduodenoscopy for evaluation of upper gastrointestinal nonneoplastic disorders in patients with fresh hypopharyngeal cancer. Laryngoscope 2013;123:975-9. https://doi.org/10.1002/lary.23726
  17. Biacabe B, Gleich LL, Laccourreye O, Hartl DM, Bouchoucha M, Brasnu D. Silent gastroesophageal reflux disease in patients with pharyngolaryngeal cancer: further results. Head Neck 1998;20:510-4. https://doi.org/10.1002/(SICI)1097-0347(199809)20:6<510::AID-HED4>3.0.CO;2-0
  18. Farwell DG, Rees CJ, Mouadeb DA, Allen J, Chen AM, Enepekides DJ, et al. Esophageal pathology in patients after treatment for head and neck cancer.Otolaryngol Head Neck Surg 2010;143:375-8. https://doi.org/10.1016/j.otohns.2010.05.006
  19. Wang CP, Lee YC, Lou PJ, Yang TL, Chen TC, Huang CC, et al. Unsedated transnasal esophagogastroduodenoscopy for the evaluation of dysphagia following treatment for previous primary head neck cancer. Oral Oncol 2009;45:615-20. https://doi.org/10.1016/j.oraloncology.2008.08.013
  20. Rees CJ. In-office unsedated transnasal balloon dilation of the esophagus and trachea. Curr Opin Otolaryngol Head Neck Surg 2007;15: 401-4. https://doi.org/10.1097/MOO.0b013e3282f1a92c
  21. Doctor VS, Enepekides DJ, Farwell DG, Belafsky PC. Transnasal oesophagoscopy-guided in-office secondary tracheoesophageal puncture. J Laryngol Otol 2008;122:303-6. https://doi.org/10.1017/S0022215107000084
  22. Nevah MI, Lamberth JR, Dekovich AA. Transnasal PEG tube placement in patients with head and neck cancer. Gastrointest Endosc 2014;79:599-604. https://doi.org/10.1016/j.gie.2013.08.019